Skip to content
Abierto

Award notice, first published as presolicitation

Montelukast 10mg Tablet

36E79725R0061

Department of Veterans Affairs, Nac Pharmaceuticals. Pharmaceutical Preparation Manufacturing.

Awarded

Xlcare Pharmaceuticals Inc.

$0.00 obligated so far on USAspending

Description

As published on SAM.gov with the solicitation of October 21, 2025.

Page 1 of Page 1 of Page 1 of Page 1 of Amendment to extend the due date of offers November 4, 2025, 2:30PM CT

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

UEI
MEAUS5WHBJJ7
CAGE
86SL9
Vendor location
Lawrenceville, GA
Contract
36E79726D0007
Obligated
$0.00, potential $24,826,671
Actions
1 between January 8, 2026 and January 8, 2026
Competition
Full and Open Competition, 2 offers received
Set-aside reported
No Set Aside Used.
Described as
3 Line Items for Montelukast 10MG Tablet. Awarded for a Base Year of 5/10/2026 to 5/9/2027 Plus 4 ONE-YEAR Option Periods.
Match
award number 36E79726D0007 equals the contract number; same awarding office 36E797 (high confidence)

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. September 12, 2025

    Presolicitation

    Montelukast 10mg Tablet (VA-25-00102867)

    Due October 10, 2025 at 3:30 PM EDT. SAM.gov, notice da5d34c5d6fd41809478a655379d730a

  2. October 17, 2025

    Solicitation, originally presolicitation

    Montelukast 10mg Tablet (VA-25-00102867)

    Due October 31, 2025 at 3:30 PM EDT. SAM.gov, notice cbc3af1d25a84162a24901024184b7c7

  3. October 20, 2025

    Solicitation

    Montelukast 10mg Tablet (VA-25-00102867)

    Due October 31, 2025 at 3:30 PM EDT. SAM.gov, notice 6529ea0b0e9c483a8fa1de00ac0ae140

  4. October 21, 2025

    Solicitation

    Montelukast 10mg Tablet (VA-25-00102867)

    Due November 4, 2025 at 3:30 PM EST. SAM.gov, notice 699be87b5c2d4bedb5552d4ceaa49b99

  5. January 9, 2026

    Award notice

    Awarded to Xlcare Pharmaceuticals Inc. Lawrenceville 30046 for $24,826,671. SAM.gov, notice a7ad94e6af8c4a168c6a092a60e00301

Points of contact